Table: begin end state 1 11 cytoplasmic 12 31 transmembrane 32 36 non-cytoplasmic 37 59 transmembrane 60 65 cytoplasmic 66 85 transmembrane 86 90 non-cytoplasmic 91 111 transmembrane 112 119 cytoplasmic 120 142 transmembrane 143 161 non-cytoplasmic 162 184 transmembrane 185 213 cytoplasmic 214 235 transmembrane 236 240 non-cytoplasmic 241 261 transmembrane 262 266 cytoplasmic 267 286 transmembrane 287 295 non-cytoplasmic 296 320 transmembrane 321 337 cytoplasmic
Input: >SM_b21017 FitnessBrowser__Smeli:SM_b21017 MKKLIFRWETALFAMLVAELLIFGLVNPRFLNLTNLIYGTSDFVQIGIVALPLTLVIIAG GIDVSFASVIGLTAIMFGVATFYGVPLPLSILLALVTGALCGLLNATVIHLSKIQPLVVT LGSLYLFQGTATVASGLVGAGGYEGIGNFPEAFNAFGYAEFLGLPAPLALFLALSLVLIV LLHFTRFGRTVFLSGQSERAAHFAGIPVGRVQTFTYVITGVSAAIAGLVMSAYFGSARVD LGSATLLPAVTAAVLGGASIYGGQGSILGTLLATFVIGYLQQGLQAAGVPSQISSALSGG LLVVAVALRHASAMLADFIAVARQQRQNRVAVTSGGE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server